Introduction
The increasing use of in vitro fertilization (IVF), with or without intracytoplasmic sperm injection (ICSI), has raised concerns about potential consequences for the resulting offspring, in particular the putative effect on the prevalence of congenital anomalies. A recent meta-analysis showed that infants born following IVF/ICSI (n = 92,671) had a relative risk of 1.32 (95% confidence interval (95%CI): 1.24-1.42) of having any birth defect compared with naturally conceived infants (n = 3,870,760) (Hansen et al. 2013) .
The increased number of birth defects in infants conceived via IVF/ICSI has been attributed both to the IVF/ICSI-procedure and the parent's underlying subfertility. A role for the IVF/ICSI-procedure is conceivable as natural selection of gametes is bypassed, early embryonic development takes place in vitro, and the embryo is transferred into an altered intra-uterine environment due to ovarian hyperstimulation. There is also evidence for a role of the underlying subfertility: untreated subfertility and a longer time to pregnancy are associated with an increased rate of birth defects (Davies et al. 2012b , Seggers et al. 2012 , Zhu et al. 2006 ).
In addition, an increased risk of imprinting disorders like Beckwith-Wiedemann syndrome and Angelman syndrome has been described after IVF/ICSI (Amor and Halliday 2008 , Ludwig et al. 2005 , Manipalviratn et al. 2009 ). There is evidence to suggest an adverse effect of the IVF/ICSI-procedures (Doherty et al. 2000 , Sato et al. 2007 , Shi and Haaf 2002 , Zaitseva et al. 2007 , as well as of the underlying subfertility (Doornbos et al. 2007 ) on imprinting status.
Previous studies often faced the limitation of either low numbers of specific congenital anomalies, or the absence of information on a history of subfertility without IVF/ICSI treatment. In case of low numbers of specific anomalies, defects were grouped together in larger subgroups for power reasons. Associations have been reported between IVF/ICSI and cardiovascular anomalies, neural tube defects, urogenital anomalies, gastrointestinal anomalies, clefts, musculoskeletal anomalies, and limb anomalies (Hansen et al. 2012 , Reefhuis et al. 2009 , Wen et al. 2012 . A disadvantage of using subgroups is that pathogenetically dissimilar congenital anomalies are pooled. This could explain why the studies provided an incoherent picture. For instance, some found an increased risk of musculoskeletal defects (Davies et al. 2012b , El-Chaar et al. 2009 , Hansen et al. 2002 , Hansen et al. 2012 , Zhu et al. 2009 ), while others did not (Ericson and Kallen 2001 , Kallen et al. 2005a , Kallen et al. 2010b , Katalinic et al. 2004 , Reefhuis et al. 2009 ). These contradictions emphasize the necessity for a novel approach evaluating the increased risk for specific types of birth defects like hip dysplasia or a club foot, instead of larger subgroups of defects such as musculoskeletal defects. In addition, knowledge about which birth defects occur more often after a history of subfertility without IVF/ICSI treatment is scarce.
Part 1 -The Eurocat Subfertility Project
To address these issues, we analysed data from Eurocat Northern Netherlands (Eurocat NNL), a voluntary population-based birth defects registry. Unlike previous studies that used non-malformed controls, we studied the effects of subfertility and IVF/ICSI in a dataset of fetuses/children that all have a congenital anomaly. This approach precludes us from investigating the overall risk for a congenital anomaly, but allows us to identify which specific congenital anomalies, imprinting disorders and syndromal disorders with unknown aetiology are associated with subfertility or IVF/ICSI.
Methods

Setting and participants
We used data from Eurocat NNL, which registers fetuses and children with congenital anomalies of mothers who lived in the registration area at the time of birth. An affected child can be registered up to the age of 10 years. Annually, Eurocat NNL monitors ~19,000 births in the Northern Netherlands. Eurocat NNL uses multiple sources for active case ascertainment in addition to notification by midwives, general practitioners, well-baby clinic doctors and medical specialists. Live births, stillbirths and pregnancies terminated due to congenital anomalies are registered on a voluntary basis. The participation rate is stable at approximately 80% for years. After consenting to registration, parents receive a questionnaire asking about their health, life style, use of medication, fertility and pregnancy; another 80% completes the questionnaire. In addition, parents are asked about inconsistencies in their answers of the questionnaire and the use of medication during pregnancy in a telephone interview.
Information on congenital anomalies is retrieved from medical files and includes results from genetic tests and pathology reports. Congenital anomalies are classified according to the 9th and 10th revisions of the WHO International Classification of Diseases (ICD). The ICD-9 classification was used up to 2001 and ICD-10 from 2002 onwards. Heart defects are further classified into septal defects, conotruncal defects, outflow tract anomalies, and other heart defects (Botto et al. 2007) . Eurocat NNL does not collect information on non-malformed fetuses/children. An overview of the procedures and findings of Eurocat can be found at http:// www.eurocat-network.eu/accessprevalencedata/prevalencetables. Parents consented to the data being registered and used in studies on risk factors for congenital anomalies. Approval from the medical ethics board was not required.
Cases registered between 1997-2010 were divided into three fertility groups: 1. Fertile parents 2. Subfertile parents who eventually conceived naturally (Sub-NC group) 3. Subfertile parents who conceived through IVF or ICSI
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Parents were categorized into one of these groups depending on their answers to the questionnaire: they were asked whether they experienced any problem conceiving. If they answered 'no' , they were considered fertile. If they answered 'yes' , parents could fill out whether they used any fertility treatment and, if so, which treatment. We searched medical records of fertility clinics of all couples stating they had fertility problems. Couples were defined as subfertile after a time to pregnancy of at least 12 months. Cases were excluded if subfertility could not be confirmed (e.g. no medical records of fertility clinics were available or a time to pregnancy < 12 months) or if any treatment other than IVF or ICSI was used.
Methods and variables
Since we were interested in the possible effect of subfertility on congenital anomalies, we excluded all cases with a known underlying cause for their anomaly, including chromosomal and monogenic disorders and defects resulting from congenital infections or exposure to teratogens. The reason for this is that demonstrating an additional effect of subfertility, when a known cause is already present, requires a larger and different population. For example, Down syndrome is known to be associated with congenital heart defects. In order to demonstrate an effect of subfertility, the question would be if children with Down syndrome are even more likely to have a heart defect in case their parents are subfertile. As we do not expect to be able to demonstrate such associations, and since adding congenital anomalies with a known cause may well mask a possible effect of subfertility on a specific anomaly, we chose to exclude cases with a known underlying cause. We did include all imprinting disorders regardless of their underlying cause. The rationale for this is that several studies reported an increased risk of imprinting disorders after IVF/ICSI. The underlying cause of the imprinting disorders is well documented in Eurocat NNL, and little is known about the effects of subfertility and the IVF/ICSI-procedure on the different causes of imprinting disorders.
If multiple congenital anomalies in one child were part of a recognized syndrome without a known cause, the presence of the syndrome was analysed, but associated anomalies were not analysed separately (e.g. a child with VATER association was not included in the analysis on heart anomalies and anal atresia). Multiple congenital anomalies which were not part of a recognized syndrome were analysed as separate anomalies (e.g. a child with a heart defect and a clubfoot was included in the analyses for both defects).
Body Mass Index (BMI) was defined as self-reported pre-pregnancy weight/ height 2 . Smoking was defined as self-reported periconceptional smoking. Folic acid use was classified into correct periconceptional use (400 or 500 μg folic acid/day from ≥4 weeks before conception until ≥8 weeks of pregnancy) or not. Education Part 1 -The Eurocat Subfertility Project levels were divided into low, middle or high. Alcohol consumption was defined as any alcohol taken in the first trimester. Diabetes included pre-pregnancy and gestational diabetes.
Statistical analysis
Background characteristics were compared for the three fertility categories using chi-square tests, Mann-Whitney U-tests or Students t-tests where applicable. We analysed a congenital anomaly if it occurred at least three times in the subfertile groups, with the exception of imprinting disorders, which were all analysed. Two comparisons were made, 1) to assess the general effect of subfertility, we pooled both subfertile groups (Sub-NC and IVF/ICSI) and compared them with the fertile group, 2) to assess the effect of the IVF/ICSI-procedure, we compared the IVF/ICSI group with the Sub-NC group.
First, crude odds ratios (ORs) of the contribution of either subfertility or IVF/ICSI to a specific congenital anomaly were determined using logistic regression analyses. A specific congenital anomaly was selected as the dependent variable (for example: penoscrotal hypospadia present of absent). IVF/ICSI or subfertility was studied as a covariate in order to calculate their effect on a specific defect (in the example on penoscrotal hypospadia). In this particular example, fetuses/children without penoscrotal hypospadia but with another defect without a known cause served as controls in the logistic regression analyses.
Second, to ensure uniformity of the results, we adjusted for maternal age at conception and correct use of folic acid, since these parameters differ between fertile and subfertile couples and are known to have an effect on congenital anomalies. Third, the role of other potential confounders was assessed when differences in the prevalence of specific congenital anomalies between fertility categories were found. These potential confounders included year of birth (as IVF/ICSI treatments and the prevalence of congenital anomalies differed through the years) and multiple pregnancies (as these occur more often after IVF/ICSI). Furthermore, covariates that showed a significant difference between our groups (maternal diabetes, DES daughters (women exposed in utero to diethylstilbestrol) and ICSI) were considered confounders if an effect of the covariate on that specific congenital anomaly was known from the literature. P-values < 0.05 and 95%CIs excluding 1.0 were regarded statistically significant. Bonferroni corrections were not applied, as the nature of this study was explorative. Analyses were performed using IBM SPSS Statistics 20.
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Results
Participation
Between 1997-2010, 7306 cases were registered by Eurocat NNL. Of these, 1049 had missing data regarding problems conceiving. 5249 Couples indicated that they did not have problems conceiving and after exclusion of cases with a known underlying cause (n = 1064), 4185 cases were included in the fertile group. 1008 Couples indicated that they had problems conceiving, after exclusion of cases born following intra-uterine insemination, hormonal or other treatment (n = 330), and cases with unconfirmed subfertility by our fertility report check (n = 218), and all cases with a known underlying cause (n = 120), 340 cases were eligible for the total subfertile group. Of these, 201 cases were conceived naturally (Sub-NC group) and 139 after IVF/ICSI. Table 1 shows the background characteristics of the three groups. Maternal age was lower in the fertile group (median 29.8 years) than in both subfertile groups (Sub-NC 32.7 years, IVF/ICSI 33.6 years). Maternal diabetes occurred more often in the Sub-NC group (4%) compared to the fertile group (2%). Women conceiving with IVF/ ICSI had more often used folic acid (75%) and more often had a multiple pregnancy (35%) than fertile women (37% and 4%, respectively) and Sub-NC women (48% and 5%, respectively). The difference in folic acid use between the Sub-NC and fertile group also reached statistical significance. Mothers in the Sub-NC group were more often DES daughters (2%) than fertile mothers (1%). Table 2 shows the number of congenital anomalies, recognized syndromes with unknown aetiology, and imprinting disorders per fertility category. Congenital anomalies that occurred less than three times in the total subfertile group were not analysed, but are described in supplemental Table 1 . As an exception, we do show all imprinting disorders in Table 2 , regardless of low numbers. (25) 57 (30) 30 (23) Correct use of folic acid, n (%) 1507 (37)*/ ^92 (48) (18) 45 (23) 27 (22) Average, n (%) b
Background characteristics
Frequencies of congenital anomalies, recognized syndromes with unknown aetiology and imprinting disorders
1993 (50) 95 (50) 55 (44) High, n (%) c 1270 (32) 52 (27) 42 (34) Congenital anomaly discovered during pregnancy, n(%)
1796 (43) 86 (43) 60 (43) Active termination of pregnancy, n(%)
262 (6) 10 (5) (1) 0 3 (2) Ear anomaly 18 (0) 1 (1) 2 (2) Clefts 368 (9) 17 (9) 11 (8) Cleft lip with or without cleft palate 250 (6) 14 (7) 7 (7) Cleft lip without cleft palate 94 (2) 7 (4) 5 (4) Cleft lip with cleft palate 156 (4) 7 (4) 2 (1) Unilateral cleft lip and palate 46 (1) 2 (1) 1 (1) Cleft palate without cleft lip 118 (3) 3 (2) 4 (3) Anomalies of the respiratory tract 76 (2) 6 (3) 1 (1) Anomalies of the digestive tract 531 (13) 35 (18) 18 (13) Anomalies of the oesophagus 44 (1) 3 (2) 1 (1)
Hypertrophic pyloric stenosis 224 (5) 14 (7) 7 (5) Atresia of the small or large intestine 78 (2) 4 (2) 4 (3)
Atresia of the small intestine 29 (1) 2 (1) 1 (1) Atresia of the large intestine 51 (1) 2 (1) 3 (2) Anorectal atresia 48 (1) 
Imprinting disorders
Any imprinting disorder 20 (1) 2 (1) 1 (1) Beckwith Wiedemann syndrome 7 (0) 1 (1) 1 (1) Silver Russell syndrome 1 (0) 1 (1) 0
Prader Willi syndrome 10 (0) 0 0
Angelman syndrome 2 (0) 0 0
Cause of imprinting disorder* Primary methylation defect 5 (0) 2 (1) 1 (1) Microdeletion 8 (0) 0 0
Uniparental disomy 4 (0) 0 0
Other causes** 2 (0) 0 0 *In one child with Prader Willi syndrome the underlying cause was unknown. **Other causes included a de novo mutation in the UBE3A gene in a child with Angelman syndrome and a translocation of chromosomes Y and 11 in a child with Beckwith-Wiedemann syndrome. Abbreviations: ASD = atrial septal defect, VSD = ventricular septal defect, AVSD = atrioventricular septal defect, RVOTO = right ventricular outflow tract obstruction, LVOTO = left ventricular outflow tract obstruction. VATER association is the non-random co-occurrence of at least three of the following: vertebral anomalies, anal atresia, cardiac defects, tracheo-esophageal fistula, renal anomalies and limb anomalies. Table 3 shows crude and adjusted ORs resulting from the logistic regression analyses. In these multivariable regression analyses, we always corrected for maternal age at conception and correct use of folic acid. In addition, we corrected for year of birth, multiple pregnancy, and defect-specific confounders where we found significant differences between the groups after correcting for maternal age and folic acid use. As can be seen in Table 3 , we found a history of subfertility to be associated with an increase in abdominal wall defects (aOR: 2.43, 95%CI: 1.05-5.62), penoscrotal hypospadia (aOR: 9.83, 95%CI: 3.58-27.04) and right ventricular outflow tract obstruction (aOR: 1.77, 95%CI: 1.05-2.96). IVF/ICSI was associated with an increase in limb anomalies (aOR: 3.31, 95%CI: 1.31-8.38), polydactyly (aOR: 4.83, 95%CI: 1.39-16.77) and polydactyly of the hands (aOR: 5.02, 95%CI: 1.43-17.65). This association between IVF/ICSI and limb anomalies was attenuated when we excluded the cases with polydactyly from the cases with limb anomalies (aOR: 1.83, 95%CI: 0.48-6.99) indicating that the increased risk of limb anomalies was dominated by an increased risk of polydactyly.
Differences in congenital anomalies per fertility category
Part 1 -The Eurocat Subfertility Project
The legend of Table 3 shows the additional confounders. The rationale for selecting defect-specific confounders was as follows: in the analyses of genital anomalies we corrected for DES daughter and ICSI as DES daughters more often give birth to a son with hypospadia (Brouwers et al. 2007 ) and ICSI may be associated with genital anomalies in the offspring (Funke et al. 2010) . In the analysis of right ventricular outflow tract obstructions (RVOTO), we also corrected for maternal diabetes (pre-existing diabetes and gestational diabetes) as heart defects occur more often in offspring of mothers with diabetes (Liu et al. 2013) . Corrected for maternal age, folic acid use, year of birth, multiple pregnancy, ICSI and DES daughters. C Corrected for maternal age, folic acid use, year of birth, multiple pregnancy and diabetes. Adjusted odds ratios not further specified were all corrected for maternal age at conception and the correct use of folic acid. Abbreviations: ASD = atrial septal defect, VSD = ventricular septal defect, AVSD = atrioventricular septal defect, RVOTO = right ventricular outflow tract obstruction, LVOTO = left ventricular outflow tract obstruction. VATER association is the non-random co-occurrence of at least three of the following: vertebral anomalies, anal atresia, cardiac defects, tracheo-esophageal fistula, renal anomalies and limb anomalies.
Recognized syndromes with unknown aetiology
Of the recognized syndromes with unknown underlying cause, only VATER association was reported at least three times in the subfertile groups and is presented in Table 2 . VATER was found four times in the IVF/ICSI group (3%) and once (1%) in the Sub-NC group; the difference was statistically not significant (p = 0.055). In the fertile group, VATER was also found in 1% (n = 23).
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Differences in imprinting disorders per fertility category Table 4 shows crude ORs for different types of imprinting disorders and their underlying causes, including primary methylation defects, microdeletions or uniparental disomy. Imprinting disorders resulting from primary methylation defects occurred more often in the total subfertile group than in the fertile group (crude OR: 6.12, 95%CI: 1.54-24.90). After correcting for maternal age at conception, correct use of folic acid, year of birth, and multiple pregnancies, the difference remained significant: aOR: 13.49 (95%CI: 2.93-62.06).
Discussion
In this registry-based birth defect study we found an increased risk of abdominal wall defects, penoscrotal hypospadia, RVOTO and methylation defects causing imprinting disorders in fetuses/children of subfertile parents (n = 340) compared to those of fertile parents (n = 4185). We also found an increased risk of polydactyly (mainly of the hands) after IVF/ICSI (n = 139) compared to the Sub-NC group (n = 201).
Some of our results are in line with the literature, while others are not. We found that abdominal wall defects occurred more often after subfertility. This is in line with studies reporting an increased risk of omphalocele (Ericson and Kallen 2001) and blastogenesis birth defects, including abdominal wall defects, after IVF/ ICSI (Halliday et al. 2010) . In these studies, the role of the underlying subfertility could not be separately assessed, but a more general association between subfertility and anomalies of the digestive system has been reported (Zhu et al. 2006) .
In our study, we found that penoscrotal hypospadia was associated with subfertility. Others have also found that of the different types of urogenital abnormalities, especially hypospadia seems to be associated with IVF/ICSI (Funke et al. 2010 , Silver et al. 1999 , Wennerholm et al. 2000 . A link between paternal subfertility and hypospadia, as well as hormonal exposure during organogenesis have been proposed as mediating factors (Ericson and Kallen 2001, Zhu et al. 2006) . Our study suggests that factors associated with subfertility are involved in the aetiology of penoscrotal hypospadia, but we did not find evidence that ICSI plays a role.
Our data further suggest that RVOTO is more common after a history of subfertility. Associations between IVF/ICSI and septal heart defects (Reefhuis et al. 2009 ) and tetralogy of Fallot (Tararbit et al. 2013) have previously been reported, although neither study could disentangle how far the observed associations could be attributed to IVF/ICSI versus the underlying subfertility. Our study allows us to separate these factors and suggests a role for a history of subfertility in RVOTO. We further found an association between IVF/ICSI and polydactyly (mainly of the Part 1 -The Eurocat Subfertility Project Table 4 . Crude odds ratios of imprinting disorders and their underlying causes associated with fertility category. Other causes included a de novo mutation in the UBE3A gene in a child with Angelman syndrome and a translocation of chromosomes Y and 11 in a child with Beckwith-Wiedemann syndrome.
Chapter 2 hands). We excluded monogenic causes of polydactyly and looked, in detail, into whether polydactyly after IVF/ICSI repeatedly occurred in combination with any other specific defect: it did not (data not shown).
Finally, we confirmed that a history of subfertility is associated with methylation defects that cause imprinting disorders. In an earlier Dutch study, the association between IVF/ICSI and Beckwith-Wiedemann syndrome and Angelman syndrome disappeared after correction for subfertility (Doornbos et al. 2007) . Imprinting disorders can occur due to disturbed methylation, microdeletions or uniparental disomy. We were able to analyse these different causes and found that a history of subfertility was associated with methylation defects. As the effects of parental subfertility on the epigenetic make-up of offspring are largely unknown, this may contribute to generating new hypotheses. Genome-wide epigenetic alterations in phenotypically normal children born following IVF/ICSI have been described (Batcheller et al. 2011) . It is possible that there is an epigenetic instability of the gametes or the early embryonic cells that results in both subfertility of the parents and adverse health outcomes in their offspring (Horsthemke and Ludwig 2005, Ludwig et al. 2005) .
Other studies reported associations between IVF/ICSI and several subgroups of congenital anomalies that we were unable to confirm. The subgroups included musculoskeletal defects, neural tube defects, digestive tract atresia, cleft lip/palate, and anomalies of the ear, eye, face and neck (Davies et al. 2012b , Ericson and Kallen 2001 , Hansen et al. 2012 , Kallen et al. 2010b , Reefhuis et al. 2009 , Wen et al. 2012 , Zhu et al. 2006 ). The fact that previous studies provide an incoherent picture of which subgroups of anomalies occur more often after IVF/ICSI might suggest that all anomalies occur more frequently after IVF. Also, as we combined all different causes of subfertility into one group, we were not able to further deduce whether specific causes of subfertility were associated with specific birth defects in our study. Furthermore, as Eurocat NNL does not include non-malformed controls, the risk increase for the overall group of congenital anomalies could not be analysed.
Strengths and limitations
One of the main strengths of our study is inclusion of all types of births, regardless of gestational age. Unlike many other studies, terminations of pregnancy due to fetal anomalies were included in this study. This is important as subfertile women may less frequently decide to terminate their much-desired pregnancies due to a congenital anomaly (Hansen et al. 2012) .
The total subfertile group consisted of 340 children. This may seem a small group, but as they all had a congenital anomaly, this sample allowed for an adequate evaluation of most specific anomalies. All congenital anomalies that occurred at least 3 times in the total subfertile group were analysed, the complete and detailed Part 1 -The Eurocat Subfertility Project overview of all anomalies is regarded one of the main strengths of the study. Yet, our power to detect associations with very rare congenital anomalies and syndromes with unknown aetiology was probably insufficient.
Another strength of our study is inclusion of children with congenital anomalies up to the age of 10 years and not just after birth. Furthermore, Eurocat NNL's long history allowed for large numbers of cases and enabled us to look at specific and pathogenetically similar types of congenital anomalies rather than larger heterogeneous subgroups. The detailed information from the parental questionnaire allowed us to adjust for a large variety of confounders. A final strength of our study is that we verified parental subfertility by searching medical records of fertility clinics.
However, searching the fertility records could also be regarded as a limitation, since we lost data by excluding those with unconfirmed subfertility. The loss of these data reduced the study power, but increased the certainty of evaluating the effect of IVF/ICSI and subfertility on congenital anomalies. Another limitation of our study is that information on fertility status and pregnancy details was obtained retrospectively with a questionnaire up to the age of 10 years, so the couples could have a problem with the recall of these details. However, problems with recall are expected to be the same for all groups and most questionnaires were returned within the first two years after the child's birth (median 1.40 years, standard deviation 2.11 years). Another limitation is that we were not certain that fertile couples were indeed fertile according to the definition of a time to pregnancy of less than 12 months. This could have induced an underestimation of the effect of subfertility on congenital anomalies in the offspring.
We analysed IVF and ICSI together which is supported by a recent metaanalysis that showed no risk differences for birth defects between IVF and ICSI children (relative risk: 1.05, 95%CI: 0.91-1.20) (Wen et al. 2012 ). We could not confirm the potential link between ICSI and urogenital anomalies reported in several other studies. We also analysed Sub-NC and IVF/ICSI together as one big subfertile group as this increases the power to detect an effect of subfertility on specific congenital anomalies. Finally, as we analysed many specific congenital anomalies (n = 85), some of the associations found could be chance findings. We deliberately did not perform Bonferroni corrections, as the nature of our study was explorative. Emphasis should be put on the point estimates of the OR's and their potential relevance rather than on their confidence intervals and p-values.
In conclusion, this study provides a structured overview of detailed and specific congenital anomalies, recognized syndromes with unknown aetiology, and imprinting disorders after a confirmed history of subfertility and IVF/ICSI. The study suggests that the previously described associations between IVF/ICSI and penoscrotal hypospadia and imprinting disorders are the result of factors associated with subfertility. (7) 10 (5) 6 (4) Neural tube defect 148 (4) 6 (3) 1 (1) Anencephaly 49 (1) 4 (2) 1 (1) Spina bifida 89 (2) 
